Correlation Between Pfizer and Bausch

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Bausch at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Bausch into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Bausch Health Companies, you can compare the effects of market volatilities on Pfizer and Bausch and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Bausch. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Bausch.

Diversification Opportunities for Pfizer and Bausch

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pfizer and Bausch is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Bausch Health Companies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bausch Health Companies and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Bausch. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bausch Health Companies has no effect on the direction of Pfizer i.e., Pfizer and Bausch go up and down completely randomly.

Pair Corralation between Pfizer and Bausch

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.5 times more return on investment than Bausch. However, Pfizer Inc is 2.01 times less risky than Bausch. It trades about -0.07 of its potential returns per unit of risk. Bausch Health Companies is currently generating about -0.09 per unit of risk. If you would invest  2,842  in Pfizer Inc on October 26, 2024 and sell it today you would lose (198.00) from holding Pfizer Inc or give up 6.97% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy66.1%
ValuesDaily Returns

Pfizer Inc  vs.  Bausch Health Companies

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Bausch Health Companies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bausch Health Companies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for Bausch Health Companies investors.

Pfizer and Bausch Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Bausch

The main advantage of trading using opposite Pfizer and Bausch positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Bausch can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch will offset losses from the drop in Bausch's long position.
The idea behind Pfizer Inc and Bausch Health Companies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets